food interaction for Alrubicin Injection

alcohol interaction for Alrubicin Injection

pregnancy interaction for Alrubicin Injection

lactation interaction for Alrubicin Injection

food
alcohol
pregnancy
lactation
No interaction found/established
It is unsafe to consume alcohol with Alrubicin 50 Injection.
UNSAFE
Alrubicin 50 Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
CONSULT YOUR DOCTOR
Alrubicin 50 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
UNSAFE

SALT INFORMATION FOR Alrubicin 50mg Injection

Epirubicin(50mg)

Alrubicin injection uses

{med_name} is used in the treatment of cancer.

How alrubicin injection works

Alrubicin 50 Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase II) involved in DNA multiplication of the breast cancer cells. It also forms harmful chemicals (free radicals) which cause DNA damage. This slows the growth of breast cancer cells and eventually kills them.

Common side effects of alrubicin injection

Low blood platelets, Nausea, Hair loss, Absence of menstrual periods, Fever, Anemia (low number of red blood cells), Diarrhea, Weight loss, Decreased white blood cell count (neutrophils), Hot flashes, Gastrointestinal inflammation, Rash, Low energy, Eye disorder

SUBSTITUTES FOR Alrubicin Injection

41 Substitutes
41 Substitutes
Sorted By
RelevancePrice
  • Epithra 50 Injection
    (1 Injection in vial)
    Glenmark Pharmaceuticals Ltd
    Rs. 1028/Injection
    Injection
    Rs. 1060
    save 10% more per Injection
  • Anthracin 50mg Injection
    (1 Injection in vial)
    Dabur India Ltd
    Rs. 59/Injection
    Injection
    Rs. 60.89
    save 95% more per Injection
  • Epineon 50mg Injection
    (1 Injection in vial)
    Neon Laboratories Ltd
    Rs. 618/Injection
    Injection
    Rs. 637.63
    save 46% more per Injection
  • Epicin 50mg Injection
    (1 Injection in vial)
    Medion Biotech Pvt Ltd
    Rs. 1520/Injection
    Injection
    Rs. 1568
    pay 33% more per Injection
  • Adricin Injection
    (25 ml Injection in vial)
    Adley Formulations
    Rs. 53.16/ml of Injection
    generic_icon
    Rs. 1370.48
    save 95% more per ml of Injection

Expert advice FOR Alrubicin Injection

  • Epirubicin is used alone or in combination with other medicines for the treatment of various types of cancers.
  • It is given through a drip into a vein (intravenous infusion) by a doctor or nurse.
  • It may make you feel tired or sleepy.  Do not drive or do anything that requires mental focus until you know how it affects you.
  • Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for 6 months after stopping treatment.
  • Your doctor may get regular blood tests done to monitor your blood cells, liver, and heart function during treatment with this medicine.
  • Inform your doctor immediately if you notice any signs of infection such as fever, sore throat or rash.

Frequently asked questions FOR Alrubicin 50mg Injection

Epirubicin

Q. Is Alrubicin 50 Injection a vesicant (agent that causes tissue blistering and damage)?
Yes, Alrubicin 50 Injection is a vesicant; it may cause tissue blistering if it leaks out of the vein.
Q. How effective is Alrubicin 50 Injection?
Alrubicin 50 Injection is effective in the treatment of various cancers including cancer of the breast, ovary, stomach, lung, bowel or rectum, malignant lymphomas (a type of blood cancer of infection-fighting cells of the blood) such as Hodgkin's disease and non-Hodgkin's lymphoma, leukemia (blood cancer), multiple myeloma (a type of blood cancer of infection-fighting cells of the blood). It may be used in bladder cancers and to prevent reoccurrence of bladder cancer after surgery. It effectively slows or stops the growth of cancer cells in the body.

Content on this page was last updated on 12 January, 2024, by Dr. Varun Gupta (MD Pharmacology)